All News

SMFM 27th Annual Meeting 2007

SMFM 27th Annual Meeting 2007

SMFM 27th Annual Meeting 2007

SMFM 27th Annual Meeting 2007

Only one in five women between the ages of 18 and 44 know their cholesterol level, despite the fact that cholesterol is a major risk factor for heart disease, the number one killer of women in the United States.

SMFM 27th Annual Meeting 2007

SMFM 27th Annual Meeting 2007

SMFM 27th Annual Meeting 2007

SMFM 27th Annual Meeting 2007

SGO Annual Meeting on Women’s Cancer in San Diego from March 3-7, 2007

SGO Annual Meeting on Women’s Cancer in San Diego from March 3-7, 2007

Our fee-for-service payment system drives up both physician and hospital costs because there's no free market for such services to restrain prices.

Observational studies and placebo-controlled clinical trials have both found that supplemental doses have a therapeutic effect in these patients.

Clinical situations that typically result in litigation and the variation in jury verdicts and awards across the nation.

The latest in medical products for obstetrics and gynecology

To guide health-care providers about the efficacy, safety, and role of local vaginal ET to treat vaginal atrophy in postmenopausal women, The North American Menopause Society has developed an evidence-based position statement.

Dr. Paidas believes LMWH is a reasonable option for certain women with FVL or PGM, while Dr. Dizon-Townson says WE need better data on benefit to justify cost and risk to the patient and health-care system.

To minimize risks like birth-related trauma and asphyxia, current management stresses early recognition via ultrasound-which allows for an attempt to correct the breech-and reliance on C/S before onset of labor.

To minimize risks like birth-related trauma and asphyxia, current management stresses early recognition via ultrasound-which allows for an attempt to correct the breech-and reliance on C/S before onset of labor.

An innovative approach to ob emergencies can make these unnerving episodes seem less like an avalanche and more like downhill skiing. One of the keys is replacing sequential with simultaneous activation of the ob team.

Although there are many advantages of solo practices, including total autonomy and not having to compromise in the practice's decisions or share in its successes, for me the disadvantages were much greater.

Question from Johanna: hormone replacement therapy My mother is 69. She had a total hysterectomy in her early 40's. She had to stop hormone treatment due to blood clots. She has not been on any HRT since. She now has bad Osteoarthritis, joint pains, muscle pains, etc. She had Lyme disease a few years ago also in severe stages (10 years ago.) She still feels better when ever they put her on any antibiotics for sore throats for instance. She had a bone density test done recently and her doctor prescribed Miacalcin. Mom has been on 1000 milligrams of Calcium with a combination pill of vitamin D and boron for years. She is becoming more and more bowlegged and has increasingly difficulty walking (it is painful) She does ride her bike since it is not a weight bearing activity. By the afternoon she is very tired. Is it too late for her to have hormone replacement therapy, what kind of doctor should she be seeing, med.'s etc.? Is there a way to reverse this process? Mom has allergies with sinus drainage and gets frequent bronchitis because of it during the winter months. She takes Allegra. Will this interfere with the Miacalcin? Any information you could possibly give me would be appreciated. Thank you very much, Johanna

Questions this month have been answered by:Barry L. Gruber, MD, OBGYN.net Osteoporosis Editorial Advisor Alice Rhoton-Vlasak, MD, OBGYN.net Osteoporosis Editorial AdvisoR. Wayne Whitted, MD, MPh, OBGYN.net Osteoporosis Editorial Advisor Harvey S.Marchbein, MD, USA, OBGYN.net Osteoporosis Chairman and Editorial Advisor

Questions this month have been answered by:Harvey S. Marchbein, MD, USA, OBGYN.net Osteoporosis Chairman and Editorial Advisor

Questions this month have been answered by:Simon Kipersztok, M.D OBGYN.net Editorial Advisor

Regional pain relief may be too risky in patients with coagulation disorders, whether they're induced by anticoagulants to manage or prevent adverse pregnancy outcomes linked with VTE or thrombophilia, or due to a coagulopathy. Benefits and risks can include a rare but catastrophic complication: spinal hematoma.

Medicine's backbeat has changed. Physician recommendations never used to be questioned. Then, managed care entered the scene and third party payers became reticent.

The latest in medical products for obstetrics and gynecology.